GSK at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
GSK takes part in 6 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions cover next-generation vaccine platforms, global access and outbreak response, along with trial design and tuberculosis vaccines. The most concrete topic is using AI, machine learning and modelling to improve vaccine manufacturing technology in Europe.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
GSK London, United Kingdom | |
Panel Mon Oct 19 12:15 Talk Mon Oct 19 15:00 Panel: Global Vaccine Access: Balancing Speed and Safety How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks. Panel Wed Oct 21 10:45 Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain. Talk Wed Oct 21 13:15 Panel Wed Oct 21 14:30 Panel: Can TB vaccines deliver on the promise? What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority. Talk Wed Oct 21 15:00 Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them. |
Instantly find 20 buyers from GSK
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction